If you need more lookups,
subscriptions start at $34 USD/month.
Scott Sheehan Location
Indianapolis, IN, US
Scott Sheehan Work
Executive Director - Due Diligence @ Eli Lilly and Company (March 2025 - Present)
Senior Director - Diligence Team Leader @ Eli Lilly and Company (March 2022 - March 2025)
Advisor - Due Diligence and External Innovation @ Eli Lilly and Company (January 2019 - March 2022)
Chief Scientific Officer - Global Molecular Design and Enabling Technologies, DCR and T @ Eli Lilly and Company (April 2017 - December 2018)
Senior Director - Molecular Design and Lead Generation Technologies, DCR and T @ Eli Lilly and Company (February 2010 - March 2017)
Interim Information Officer - Research IT @ Eli Lilly and Company (July 2014 - November 2015)
Director - Discovery Chemistry Research and Technology @ Eli Lilly and Company (August 2009 - February 2010)
Head - Fragment Based Drug Discovery - Discovery Chemistry Research and Technology @ Eli Lilly and Company (January 2009 - July 2009)
Head - Discovery Chemistry Research and Technology - Diabetes Research @ Eli Lilly and Company (January 2007 - December 2008)
Head - Discovery Chemistry Research and Technology - Neurodegeneration Research @ Eli Lilly and Company (January 2006 - December 2006)
Principal Research Scientist @ Eli Lilly and Company (January 2004 - December 2005)
Senior Organic Chemist @ Eli Lilly and Company (June 2000 - December 2003)
Post-Doc. Matthew Shair Lab @ (May 1998 - June 2000)
Scott Sheehan Education
Harvard University
post-doc (Chemistry)
1998-2000
Emory University
Ph.D. (Organic Chemistry)
1993-1998
Worcester Polytechnic Institute
BS (Chemistry)
1989-1993
Scott Sheehan Skills
Drug Discovery
Lifesciences
CRO
Chemistry
Pharmaceutical Industry
Organic Synthesis
Computational Chemistry
Biomarker Discovery
Analytical Chemistry
Organic Chemistry
Medicinal Chemistry
Oncology
Technology Transfer
Drug Development
Biotechnology
Drug Design
Life Sciences
HPLC
Laboratory
Parallel Synthesis
Research
Cheminformatics
ADME
Clinical Development
Lead Change
R&D
Diabetes
CRO Management
Research and Development (R&D)
High-Performance Liquid Chromatography (HPLC)
High Performance Liquid Chromatography Hplc
Research and Development R&d
Research and Development
High Performance Liquid Chromatography
Scott Sheehan Summary
Scott Sheehan, based in Indianapolis, IN, US, is currently a Executive Director - Due Diligence at Eli Lilly and Company. Scott Sheehan brings experience from previous roles at Eli Lilly and Company. Scott Sheehan holds a 1998 - 2000 post-doc in Chemistry @ Harvard University. With a robust skill set that includes Drug Discovery, Lifesciences, CRO, Chemistry, Pharmaceutical Industry and more. Scott Sheehan has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Scott Sheehan?
Find contact details for 700 million professionals.